Biotech Will Recover!

October 15, 2002
G. Steven Burrill

Chief Executive Officer at Burrill & Company

BioPharm International, BioPharm International-10-01-2002, Volume 15, Issue 10

by G. Steven Burrill, Burrill & Company Beleagured by bad news since the start of the year, biotech is barely registering a pulse on Wall Street . . . but it's hardly time to write the industry's obituary.